Education

Biosimilars in Patients with Crohn’s Disease Failing an Initial Biologic

Array

Activity Info

Upon completion of the activity, participants should be able to explain the circumstances – and rationale – under which it is appropriate to initiate or switch a patient with inflammatory bowel disease to a biosimilar.
2. Explain the circumstances under which it is appropriate to initiate or switch a patient with inflammatory bowel disease to a biosimilar
Email

CME/CE credit is no longer available for this activity.

Tags

Webinar | 0.50 - 30 mins | Gastroenterology | Internal Medicine | Family Medicine | Nurse | Biosimilars | BiosimilarsCME.org | Online | Pharmacist | 

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

Chandler Building, 84 Lyme Street, Old Lyme, CT USA